Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
NovoCure Limited
About NVCR
NovoCure Limited is a global oncology company with a proprietary platform technology called Tumor Treating Fields (TTFields), which are electric fields that exert physical forces to kill cancer cells via a variety of mechanisms. The Company's commercialized products are approved in certain countries for the treatment of adult patients with glioblastoma, non-small cell lung cancer, malignant pleural mesothelioma and pleural mesothelioma. Its Optune Gio is approved by the FDA under the Premarket Approval pathway for the treatment of adult patients with newly diagnosed glioblastoma together with temozolomide, a chemotherapy drug, and for adult patients with GBM following confirmed recurrence after chemotherapy as monotherapy treatment. Its Optune Lua is approved by the FDA under the PMA pathway for the treatment of adult patients with metastatic non-small cell lung cancer concurrent with PD-1/PD-L1 inhibitors or docetaxel following progression on or after a platinum-based regimen.
Market Capitalisation
$2.12B
Price-earnings ratio
-
Dividend yield
0.00%
Volume
833.91K
High today
$18.51
Low today
$17.84
Open price
$18.12
52-week high
$20.06
52-week low
$9.82
Ready to start your investing journey with Stake?
Open an accountHow do I buy NVCR shares in Australia?
Buying NVCR shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in NovoCure Limited in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in NVCR
What is the ticker symbol of NovoCure Limited?
The ticker symbol for NovoCure Limited is NVCR.
How much is one share of NVCR?
One share of NVCR is valued at $18.14 as of 13 May 2026.
What is the market capitalisation of NovoCure Limited NVCR?
As of 13 May 2026 NovoCure Limited has a market cap of $2.12B.
What is the 52-week high for NovoCure Limited stock?
The NovoCure Limited 52-week high stock price is $20.06.
What is the 52-week low for NovoCure Limited stock?
The NovoCure Limited 52-week low stock price is $9.82.
Can I buy NVCR shares through Stake, an investing platform like Sharesies and Hatch Invest?
Yes, the Stake investing platform allows you to buy NVCR shares and over 9,500 more stocks and ETFs on Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in NVCR on Stake
- Buy NVCR from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of NVCR from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
NVCR related stocks